Ravindra Kumar, SVP & Chief Scientific Officer at ACCELERON PHARMA INC (XLRN), sold 52,486 shares at $34.00 ($1.8M) on 2016-10-07, disclosed to the SEC on 2016-10-11.
Scheduled sale ($1.8M) by SVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.31 | 14,448 | $496K | 27.8% |
| 2 | $34.98 | 1,561 | $55K | 3.1% |
| 3 | $33.37 | 19,616 | $655K | 36.8% |
| 4 | $34.00 | 28 | $952 | 0.1% |
| 5 | $34.14 | 16,833 | $575K | 32.3% |
| Total | $33.92 avg | 52,486 |
| $1.8M |
| 100% |
| Filing → |
| XLRN | SELL | 2019-01-04 | $249K | — | Filing → |
| XLRN | SELL | 2018-04-04 | $46K | — | Filing → |
| XLRN | SELL | 2018-01-04 | $182K | — | Filing → |